The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

On Tuesday, SAB BIO (NASDAQ:SABS) released topline data from a Phase 1 trial of SAB-142 in a single-ascending dose among healthy volunteers. The study met its primary safety and pharmacodynamic ...

Betterware de Mexico SAB de CV (BWMX) declares $0.3252/share quarterly dividend, 6.2% increase from prior dividend of $0.3063. Forward yield 7.51% Payable Aug. 20; for shareholders of record Aug. 6; ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

SAB plans to be listed on NASDAQ following the closing of the transaction. The proposed transaction implies an enterprise value for SAB, on a post-merger basis, of approximately $325 million (assuming ...

Preston Pysh explains how the rescission of SAB 121 could permanently entrench Bitcoin into the financial system, surpassing the importance of a Strategic Bitcoin Reserve. In the rapidly evolving ...

The FDA has granted Breakthrough Therapy Designation (BTD) to SAB Biotherapeutics Inc's (NASDAQ:SABS) SAB-176, an investigational therapy for post-exposure prophylaxis for Type A and Type B influenza ...

Positive clinical results confirm that SAB’s fully-human polyclonal antibodies can be broadly neutralizing to both known and unknown viral variants—a valuable feature when addressing rapidly mutating ...

SIOUX FALLS, S.D.--(BUSINESS WIRE)--SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, ...